Financing Supports Continued Development of Vesper Medical's Duo Venous Stent System

 

May 30, 2019—Vesper Medical, Inc. announced $37 million financing that the company plans to use to complete the development of its Vesper Duo venous stent system, including a large, pivotal clinical trial and subsequent submission of a premarket approval application to the FDA. A portion of the financing will also be used to obtain European CE Mark certification for the Vesper Duo stents.

Vensana Capital and Gilde Healthcare are the lead investors and were joined by existing investors New Enterprise Associates and Quaker Partners. The first tranche of the financing has closed, and future tranches will close as the company achieves key milestones.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.